View in EDS

Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancer.

Saved in:
Bibliographic Details
Title: Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancer.
Authors: Labrosse KB; Department of Biomedicine, Ovarian Cancer Research, University Hospital Basel and University of Basel, Basel, Switzerland.; Department of Gynecology and Gynecological Oncology, Hospital for Women, University Hospital Basel, Basel, Switzerland., Lombardo FC; Department of Biomedicine, Ovarian Cancer Research, University Hospital Basel and University of Basel, Basel, Switzerland., Bartoszek EM; Department of Biomedicine, Microscopy Core Facility, University of Basel, Basel, Switzerland., Sauteur L; Department of Biomedicine, Microscopy Core Facility, University of Basel, Basel, Switzerland., Tanner N; Department of Biomedicine, Ovarian Cancer Research, University Hospital Basel and University of Basel, Basel, Switzerland., Tanna T; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Wolf A; Department of Biomedicine, Ovarian Cancer Research, University Hospital Basel and University of Basel, Basel, Switzerland., Tunkova B; Sotio Biotech a.s., Prague, Czech Republic.; Department of Immunology, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic., Kasikova L; Sotio Biotech a.s., Prague, Czech Republic., Fedier A; Department of Biomedicine, Ovarian Cancer Research, University Hospital Basel and University of Basel, Basel, Switzerland., Lopez MN; Department of Biomedicine, Ovarian Cancer Research, University Hospital Basel and University of Basel, Basel, Switzerland., Alborelli I; Institute of Biomedical Genetics and Pathology, University of Basel, Basel, Switzerland., Beisel C; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Kurzeder C; Department of Gynecology and Gynecological Oncology, Hospital for Women, University Hospital Basel, Basel, Switzerland., Montavon C; Department of Gynecology and Gynecological Oncology, Hospital for Women, University Hospital Basel, Basel, Switzerland., Fucíkova J; Sotio Biotech a.s., Prague, Czech Republic.; Department of Immunology, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic., Heinzelmann-Schwarz V; Department of Biomedicine, Ovarian Cancer Research, University Hospital Basel and University of Basel, Basel, Switzerland.; Department of Gynecology and Gynecological Oncology, Hospital for Women, University Hospital Basel, Basel, Switzerland., Jacob F; Department of Biomedicine, Ovarian Cancer Research, University Hospital Basel and University of Basel, Basel, Switzerland. francis.jacob@unibas.ch., Coelho R; Department of Biomedicine, Ovarian Cancer Research, University Hospital Basel and University of Basel, Basel, Switzerland. ricardojorge.bouca-novacoelho@unibas.ch.
Source: NPJ precision oncology [NPJ Precis Oncol] 2026 Feb 06; Vol. 10 (1). Date of Electronic Publication: 2026 Feb 06.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41651935
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Labrosse+KB%22">Labrosse KB</searchLink>; Department of Biomedicine, Ovarian Cancer Research, University Hospital Basel and University of Basel, Basel, Switzerland.; Department of Gynecology and Gynecological Oncology, Hospital for Women, University Hospital Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lombardo+FC%22">Lombardo FC</searchLink>; Department of Biomedicine, Ovarian Cancer Research, University Hospital Basel and University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bartoszek+EM%22">Bartoszek EM</searchLink>; Department of Biomedicine, Microscopy Core Facility, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sauteur+L%22">Sauteur L</searchLink>; Department of Biomedicine, Microscopy Core Facility, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tanner+N%22">Tanner N</searchLink>; Department of Biomedicine, Ovarian Cancer Research, University Hospital Basel and University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tanna+T%22">Tanna T</searchLink>; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wolf+A%22">Wolf A</searchLink>; Department of Biomedicine, Ovarian Cancer Research, University Hospital Basel and University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tunkova+B%22">Tunkova B</searchLink>; Sotio Biotech a.s., Prague, Czech Republic.; Department of Immunology, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Kasikova+L%22">Kasikova L</searchLink>; Sotio Biotech a.s., Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Fedier+A%22">Fedier A</searchLink>; Department of Biomedicine, Ovarian Cancer Research, University Hospital Basel and University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lopez+MN%22">Lopez MN</searchLink>; Department of Biomedicine, Ovarian Cancer Research, University Hospital Basel and University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Alborelli+I%22">Alborelli I</searchLink>; Institute of Biomedical Genetics and Pathology, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Beisel+C%22">Beisel C</searchLink>; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kurzeder+C%22">Kurzeder C</searchLink>; Department of Gynecology and Gynecological Oncology, Hospital for Women, University Hospital Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Montavon+C%22">Montavon C</searchLink>; Department of Gynecology and Gynecological Oncology, Hospital for Women, University Hospital Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Fucíkova+J%22">Fucíkova J</searchLink>; Sotio Biotech a.s., Prague, Czech Republic.; Department of Immunology, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Heinzelmann-Schwarz+V%22">Heinzelmann-Schwarz V</searchLink>; Department of Biomedicine, Ovarian Cancer Research, University Hospital Basel and University of Basel, Basel, Switzerland.; Department of Gynecology and Gynecological Oncology, Hospital for Women, University Hospital Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jacob+F%22">Jacob F</searchLink>; Department of Biomedicine, Ovarian Cancer Research, University Hospital Basel and University of Basel, Basel, Switzerland. francis.jacob@unibas.ch.<br /><searchLink fieldCode="AU" term="%22Coelho+R%22">Coelho R</searchLink>; Department of Biomedicine, Ovarian Cancer Research, University Hospital Basel and University of Basel, Basel, Switzerland. ricardojorge.bouca-novacoelho@unibas.ch.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101708166%22">NPJ precision oncology</searchLink> [NPJ Precis Oncol] 2026 Feb 06; Vol. 10 (1). <i>Date of Electronic Publication: </i>2026 Feb 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101708166 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2397-768X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222397768X%22">2397768X </searchLink><i>NLM ISO Abbreviation: </i>NPJ Precis Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41651935
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41698-026-01321-4
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Labrosse KB
      – PersonEntity:
          Name:
            NameFull: Lombardo FC
      – PersonEntity:
          Name:
            NameFull: Bartoszek EM
      – PersonEntity:
          Name:
            NameFull: Sauteur L
      – PersonEntity:
          Name:
            NameFull: Tanner N
      – PersonEntity:
          Name:
            NameFull: Tanna T
      – PersonEntity:
          Name:
            NameFull: Wolf A
      – PersonEntity:
          Name:
            NameFull: Tunkova B
      – PersonEntity:
          Name:
            NameFull: Kasikova L
      – PersonEntity:
          Name:
            NameFull: Fedier A
      – PersonEntity:
          Name:
            NameFull: Lopez MN
      – PersonEntity:
          Name:
            NameFull: Alborelli I
      – PersonEntity:
          Name:
            NameFull: Beisel C
      – PersonEntity:
          Name:
            NameFull: Kurzeder C
      – PersonEntity:
          Name:
            NameFull: Montavon C
      – PersonEntity:
          Name:
            NameFull: Fucíkova J
      – PersonEntity:
          Name:
            NameFull: Heinzelmann-Schwarz V
      – PersonEntity:
          Name:
            NameFull: Jacob F
      – PersonEntity:
          Name:
            NameFull: Coelho R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 02
              Text: 2026 Feb 06
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2397-768X
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ precision oncology
              Type: main
ResultId 1